Litcius/Paper detail

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

Chiara Ciccarese, Roberto Iacovelli, Camillo Porta, Giuseppe Procopio, Emilio Bria, Serena Astore, Maria Antonella Cannella, Giampaolo Tortora

2021Cancer Treatment Reviews37 citationsDOI

Topics & Concepts

MedicineSunitinibInternal medicineOncologyRenal cell carcinomaHazard ratioNivolumabMeta-analysisPopulationCochrane LibraryCancerImmunotherapyConfidence intervalEnvironmental healthRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis | Litcius